Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 3/20 | 0.39 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.38 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.38 |
| ▸ | ITGAL | P20701 | 2/20 | 0.38 |
| ▸ | MME | P08473 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 5/20 | 0.36 |
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 2/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | TMPRSS15 | P98073 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29913867 | 0.94 | ECE1 (0.36) | ECE1ITGB2ICAM1ITGALMME | |
| SCHEMBL31707374 | 0.94 | MME (0.38) | ECE1ITGB2ICAM1ITGALMME | |
| SCHEMBL30192164 | 0.94 | BACE1 (0.36) | ECE1ITGB2ICAM1ITGALMME | |
| SCHEMBL29360643 | 0.91 | MME (0.42) | ECE1MMECA2CA1 | |
| SCHEMBL29986038 | 0.90 | PDCD1LG2 (0.39) | ECE1BACE1 | |
| SCHEMBL29383357 | 0.90 | ECE1 (0.34) | ECE1MME | |
| SCHEMBL29630501 | 0.90 | BACE1 (0.34) | ECE1MMEBACE1 | |
| SCHEMBL23598223 | 0.90 | MME (0.35) | MME | |
| SCHEMBL2958246 | 0.90 | MME (0.35) | MME | |
| SCHEMBL9665040 | 0.90 | MME (0.35) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111602822-B | Liver fat synthesis inhibitor | 不二制油集团控股株式会社 | 2024-10-01 | — | — | CN | claimed |
| CN-117947053-A | PAM1 gene mutant for improving ethanol tolerance and application thereof | 南京理工大学 | 2024-04-30 | — | — | CN | claimed |
| CN-115047120-A | Dansyl chloride derivatization method for analyzing and detecting dipeptide substances in white spirit Daqu | 贵州茅台酒股份有限公司 | 2022-09-13 | — | — | CN | claimed |
| EP-3529371-B1 | A FUNCTIONAL DETECTION ASSAY DEVOID OF ANTIBODIES FOR SEROTYPING OF BOTULINUM NEUROTOXINS | TOXOGEN GMBH (DE) | 2022-06-22 | — | — | EP | claimed |
| EP-4051402-B1 | CELL SELECTION AND/OR STIMULATION DEVICES AND METHODS OF USE | C3S2 GMBH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4684030-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2026-01-28 | — | — | EP | disclosed |
| EP-4658798-A2 | INTEIN-MEDIATED RECONSTITUTION OF VOLTAGE-GATED SODIUM CHANNEL FUNCTION | Allen Institute (US) | 2025-12-10 | — | — | EP | disclosed |
| WO-2025038955-A9 | SYSTEMS AND METHODS FOR IMPROVING SAFETY OF SPLIT INTEIN AAV MEDIATED GENE THERAPY | SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) | 2025-04-24 | — | — | WO | disclosed |
| EP-4519427-A1 | TSPAN2 AS SCAFFOLD PROTEIN FOR ENGINEERED EXTRACELLULAR VESICLES | Evox Therapeutics Limited (GB) | 2025-03-12 | — | — | EP | disclosed |
| WO-2024227957-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2024-11-07 | — | — | WO | disclosed |
| CN-111602822-B | Liver fat synthesis inhibitor | 不二制油集团控股株式会社 | 2024-10-01 | — | — | CN | disclosed |
| CN-111602822-B | Liver fat synthesis inhibitor | 不二制油集团控股株式会社 | 2024-10-01 | — | — | CN | disclosed |
| CN-116171282-A | Soluble NPY2 receptor agonists | 勃林格殷格翰国际有限公司 | 2023-05-26 | — | — | CN | disclosed |
| WO-2023285489-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | INTERVET INTERNATIONAL B.V. (NL) | 2023-01-19 | — | — | WO | disclosed |
| US-11541111-B2 | Optimized polypeptide for a subunit vaccine against avian reovirus | Gavish-Galilee Bio Applications, Ltd. (IL) | 2023-01-03 | — | — | US | disclosed |
| CN-115047120-A | Dansyl chloride derivatization method for analyzing and detecting dipeptide substances in white spirit Daqu | 贵州茅台酒股份有限公司 | 2022-09-13 | — | — | CN | disclosed |
| CN-114702581-A | Universal carbohydrate compositions and methods for enhancing antibody efficacy | 台湾地区“中央研究院” | 2022-07-05 | — | — | CN | disclosed |
| US-20220195529-A1 | ISOFORMS OF GATA6 AND NKX2-1 AS MARKERS FOR DIAGNOSIS AND THERAPY OF CANCER AND AS TARGETS FOR ANTI-CANCER THERAPY | MAX PLANCK GESELLSCHAFT (DE) | 2022-06-23 | — | — | US | disclosed |
| EP-3529371-B1 | A FUNCTIONAL DETECTION ASSAY DEVOID OF ANTIBODIES FOR SEROTYPING OF BOTULINUM NEUROTOXINS | TOXOGEN GMBH (DE) | 2022-06-22 | — | — | EP | disclosed |
| WO-2022029231-A1 | SOLUBLE NPY2 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-02-10 | — | — | WO | disclosed |